Cierra N. Sharp

Cierra N. Sharp

Jun 01, 2016

Group 6 Copy 59
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The cost of being super-fly: The effects of Vespa Amino Acid Mixture on cellular repair mechanisms

    The aim of this project is to discover how Vespa Amino Acid Mixture (VAAM), a metabolic accelerant, impacts...

    Where is this vulnerable Indian Ocean seabird feeding? Using micro-GPS to track seabirds in the Indian Ocean

    Thankyou all! Please continue as it all helps! I have studied the Lesser Noddy at the Houtman Abrolhos, Western...

    The worm that must be named: Schikhobalotrema n.sp.

    Trematodes are a highly diverse group of parasitic flatworms with complex multi-host life-cycles. I’ve collected...

    Backer Badge Funded